Thi Khanh Le

9PUBLICATIONS
17CO-AUTHORS
Molecular targetsOncology and carcinogenesis not elsewhere classifiedMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 18, 2026
Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancer.

|Mar 28, 2026
Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773.

Asma Bourefis, Hajira Berredjem, Omar Djeffal

|Jul 10, 2025
Author Correction: Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs.

Virginie Baylot, Thi Khanh Le, David Taïeb

|Apr 23, 2024
Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs.

Virginie Baylot, Thi Khanh Le, David Taïeb

|Oct 28, 2023
Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments.

Thi Khanh Le, Quang Hieu Duong, Virginie Baylot

|Jul 29, 2023
ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines.

Sandra Udu-Ituma, José Adélaïde, Thi Khanh Le

Pageof 2

Frequent Collaborators

6 joint publications

Palma Rocchi

3 joint publications

Virginie Baylot

2 joint publications

Sébastien Benizri

2 joint publications

Philippe Barthélémy